API Holdings Limited, commonly known as PharmEasy, is India's largest digital healthcare platform, primarily involved in the trading of pharmaceutical and cosmetic goods, as well as providing various healthcare services. The company was incorporated on March 31, 2019, and has since evolved into a comprehensive digital healthcare ecosystem.
Checking authentication...
Checking authentication...
PharmEasy is poised for a stronger financial future as Manipal Group proposes a substantial investment. This injection of funds will enable the online pharmacy leader to significantly reduce its debt and enhance its market position, setting the stage for future growth and profitability.
API Holdings, the parent company of India's largest online pharmacy PharmEasy, has filed for a Rs 6,250-crore IPO, offering insights into its operations and the rapidly growing online pharmacy market in India.
PharmEasy is poised for a stronger financial future as Manipal Group proposes a substantial investment. This injection of funds will enable the online pharmacy leader to significantly reduce its debt and enhance its market position, setting the stage for future growth and profitability.
API Holdings, the parent company of India's largest online pharmacy PharmEasy, has filed for a Rs 6,250-crore IPO, offering insights into its operations and the rapidly growing online pharmacy market in India.
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
The current market price of Pharmeasy API Holdings Ltd unlisted shares is ₹7.5 per share.
The minimum lot size is ₹1000.0 shares, and trades must be placed in multiples of this.
The shares have traded as high as ₹13 and as low as ₹8 over the past year.
The shares are held in NSDL&CDSL depositories under ISIN INE0DJ201029.
Pharmeasy API Holdings Ltd Shares's market capitalization is approximately 541114 crore.
The company has P/E ratio of -₹96.6, P/B ratio of 1.14, Debt-to-Equity ratio of -, ROE of -%.
The book value of Pharmeasy API Holdings Ltd Shares is ₹7.7 per share.
The face value of Pharmeasy API Holdings Ltd unlisted shares is ₹1.0 per share.
Pharmeasy API Holdings Ltd Shares has 6142041070 shares outstanding.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.